Lagipra clinical trials

J2R-MC-YAAD: A Phase 2, Double-blind, Placebo-Controlled Study to Evaluate LY3537021 for the Treatment of Chemotherapy-Induced Nausea and Vomiting in Adult Participants With Malignant Disease

This study is looking into a new medicine called LY3537021 (also known as Lagipra) to help prevent sickness and vomiting caused by chemotherapy. It compares the new medicine to a dummy pill (placebo) and other common anti-sickness treatments in adults having cancer treatment.